Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 03, 2023

SELL
$418.69 - $503.0 $70,758 - $85,007
-169 Reduced 25.88%
484 $232,000
Q4 2022

Jan 06, 2023

SELL
$351.71 - $456.01 $85,465 - $110,810
-243 Reduced 27.12%
653 $275,000
Q3 2022

Oct 03, 2022

SELL
$412.59 - $563.26 $90,357 - $123,353
-219 Reduced 19.64%
896 $374,000
Q2 2021

Jul 07, 2021

SELL
$576.64 - $649.04 $75,539 - $85,024
-131 Reduced 10.51%
1,115 $718,000
Q1 2021

May 03, 2021

SELL
$547.01 - $662.35 $2,188 - $2,649
-4 Reduced 0.32%
1,246 $712,000
Q4 2020

Feb 18, 2021

BUY
$510.68 - $643.45 $510 - $643
1 Added 0.08%
1,250 $729,000
Q3 2020

Nov 03, 2020

BUY
$454.43 - $535.6 $146,780 - $172,998
323 Added 34.88%
1,249 $644,000
Q2 2020

Jul 20, 2020

BUY
$334.87 - $493.06 $44,537 - $65,576
133 Added 16.77%
926 $418,000
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $70,082 - $89,586
219 Added 38.15%
793 $278,000
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $183,525 - $214,790
574 New
574 $212,000
Q3 2019

Nov 04, 2019

SELL
$304.55 - $345.24 $196,130 - $222,334
-644 Closed
0 $0
Q4 2018

May 22, 2019

BUY
$220.1 - $309.0 $141,744 - $198,996
644 New
644 $150,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.